Otezla (apremilast) can cause side effects that range from mild to serious. More common side effects include headache, upper respiratory infection, and nausea. If side effects from Otezla become ...
Otezla (apremilast) is prescribed to treat psoriatic arthritis and certain other conditions. It works by reducing the activity of the immune system. Your response to this drug may depend on your ...
In an SEC filing, BMS says that it has decided that parting with Otezla (apremilast) – which earned $1.6 billion for Celgene last year – was a reasonable price to pay to bring the merger to ...
Otezla (apremilast) is Celgene's attempt to break into the immunology field currently dominated by the TNF blocker drugs, led by AbbVie's Humira. The oral treatment has a novel mechanism ...
19d
MedPage Today on MSNTYK2 Inhibitor Scores Two Wins Outside Plaque PsoriasisThe TYK2 inhibitor deucravacitinib (Sotyktu) showed clinical potential in two diseases other than psoriasis, according to studies reported here. More than half of patients with psoriatic arthritis ...
For tolerability analysis, the investigators used an additional safety reference arm related to apremilast, a psoriatic ...
Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results